Table 3 Hallmarks of Equitable Trials
From: Advancing equitable access to innovation in breast cancer
Aim | Improve patient outcomes with right-sized therapies |
---|---|
Time Frame | Flexible and contingent on study endpoint |
Design | Pragmatic, decentralized and hybrid (integrated real world data component) |
Patient Partner Role | Active and early participation in design, conduct and analysis |
Infrastructure | Physical and digital |
Trial Staff | Supports, mentors and encourages new and existing staff |
Data Access | Collaborative Data Sharing |
Translational Studies | Collaborative Biobank Access |